Oct 07, 2020
Health Canada Approves ZEPOSIA®, an Oral Treatment for Relapsing Remitting Multiple Sclerosis
Jun 23, 2020
STORM Therapeutics Appoints Dr. Josefin-Beate Holz as Chief Medical Officer
Jun 22, 2020
Sutro Biopharma Presents New Preclinical Data at 2020 AACR Virtual Annual Meeting II Suggesting Synergy between its STRO-002 Antibody-Drug Conjugate and Immune Checkpoint Inhibitors Resulting in Tumor Regression and Adaptive Anti-Tumor Immunity
Jun 18, 2020
ArcherDX Enters Collaboration with Bristol Myers Squibb to Apply Personalized Cancer Monitoring (PCM(TM)) to Clinical Research
Jun 17, 2020
Leukemia Therapeutics Markets, 2015-2025 - Size by Value & Volume, Trends & Developments, Competitive Landscape
Jun 11, 2020
Harbour BioMed Appoints Dr. Jon Wigginton to its Scientific Advisory Board
Jun 10, 2020
Biohaven Appoints Bob Hugin to its Board of Directors
Jun 02, 2020
World Market for Next Generation Immune Checkpoint Inhibitors and Stimulators - Forecast and Opportunity Analysis
Jun 01, 2020
Compugen Announces FDA Clearance of IND Application for Phase 1/2 Triple Combination Study of COM701 with Bristol Myers Squibb's Opdivo® (Nivolumab) and TIGIT Inhibitor
May 31, 2020
Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
May 22, 2020
Nektar Therapeutics Announces Publication of Results from Phase 1 Dose-Escalation Study for Bempegaldesleukin Plus Nivolumab in 'Cancer Discovery' Journal
May 21, 2020
Sutro Biopharma Expands Senior Management with the Additions of Vice President of Clinical Development and Vice President of Finance and Controller
May 19, 2020
Tolero Pharmaceuticals Submits Investigational New Drug Application for Experimental PKM2 Activator TP-1454
May 14, 2020
Biomarker Partnering Terms and Agreements, Worldwide, 2014 to 2020 - Provides Access to Headline, Upfront, Milestone and Royalty Data
May 14, 2020
Halozyme To Receive $15 Million Milestone Payment From Janssen
May 13, 2020
Artax Biopharma Appoints Joseph Lobacki as Chief Executive Officer, Announces Expanded Management Team
May 12, 2020
GRYT Health and Bristol Myers Squibb Team Up to Launch COVID Advocacy Exchange for Patient Advocates
May 11, 2020
Sutro Biopharma Announces Proposed Public Offering
May 11, 2020
VIVA Physicians Publishes Analysis Evaluating Mortality and Paclitaxel-Coated Devices
May 11, 2020
Sutro Biopharma Reports First Quarter 2020 Financial Results and Recent Business Highlights and Developments